Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.8%

2 terminated/withdrawn out of 17 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

12%

2 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed trials have results

Key Signals

3 recruiting4 with results

Enrollment Performance

Analytics

Phase 2

5(38.5%)

Phase 1

4(30.8%)

N/A

2(15.4%)

Phase 4

1(7.7%)

Phase 3

1(7.7%)

13Total

Phase 2(5)

Phase 1(4)

N/A(2)

Phase 4(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials

NCT00579072Active Not Recruiting

The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older

Role: collaborator

NCT04119024Phase 1Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Role: collaborator

NCT01025089Phase 2Active Not Recruiting

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Role: collaborator

NCT01196936Phase 2Active Not Recruiting

Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors

Role: collaborator

NCT06552416Phase 1Recruiting

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

Role: collaborator

NCT05176756Not ApplicableCompleted

RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)

Role: collaborator

NCT00903591Active Not Recruiting

Study of Radiation Exposure and Bilateral Breast Cancer

Role: collaborator

NCT06582914Recruiting

Lynch Syndrome Integrative Epidemiology and Genetics

Role: collaborator

NCT00580476Completed

Assessing Depression in a Geriatric Cancer Population

Role: collaborator

NCT00554515Phase 2Completed

The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma

Role: collaborator

NCT02054741Not ApplicableCompleted

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

Role: collaborator

NCT00325741Phase 1Terminated

Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus

Role: collaborator

NCT00515411Phase 2Completed

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Role: collaborator

NCT03279133Phase 4Withdrawn

Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients.

Role: collaborator

NCT02943642Phase 2Unknown

Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides

Role: collaborator

NCT00275665Phase 3Completed

The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.

Role: collaborator

NCT00144729Phase 1Completed

Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor

Role: collaborator

All 17 trials loaded